Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 256

1.

Efficacy of monoclonal anti-tumour necrosis factor-α antibodies in uveitic macular oedema.

Tosi GM, Vitale A, Rigante D, Sota J, Emmi G, Lopalco G, Guerriero S, Iannone F, Vannozzi L, Bitossi A, Frediani B, Cantarini L, Fabiani C.

Clin Exp Rheumatol. 2019 Oct 17. [Epub ahead of print]

PMID:
31694738
2.

Correction for: LAV-BPIFB4 associates with reduced frailty in humans and its transfer prevents frailty progression in old mice.

Malavolta M, Dato S, Villa F, De Rango F, Iannone F, Ferrario A, Maciag A, Ciaglia E, D'amato A, Carrizzo A, Basso A, Orlando F, Provinciali M, Madeddu P, Passarino G, Vecchione C, Rose G, Puca AA.

Aging (Albany NY). 2019 Oct 25;11(20):9220. doi: 10.18632/aging.102398. Epub 2019 Oct 25. No abstract available.

3.

Imputing missing data of function and disease activity in rheumatoid arthritis registers: what is the best technique?

Mongin D, Lauper K, Turesson C, Hetland ML, Klami Kristianslund E, Kvien TK, Santos MJ, Pavelka K, Iannone F, Finckh A, Courvoisier DS.

RMD Open. 2019 Oct 17;5(2):e000994. doi: 10.1136/rmdopen-2019-000994. eCollection 2019.

4.

Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpA.

Brahe CH, Ørnbjerg LM, Jacobsson L, Nissen MJ, Kristianslund EK, Mann H, Santos MJ, Reino JG, Nordström D, Rotar Z, Gudbjornsson B, Onen F, Codreanu C, Lindström U, Möller B, Kvien TK, Pavelka K, Barcelos A, Sánchez-Piedra C, Eklund KK, Tomšič M, Love TJ, Can G, Ionescu R, Loft AG, van der Horst-Bruinsma IE, Macfarlane GJ, Iannone F, Hyldstrup LH, Krogh NS, Østergaard M, Hetland ML.

Rheumatology (Oxford). 2019 Oct 30. pii: kez427. doi: 10.1093/rheumatology/kez427. [Epub ahead of print]

PMID:
31665497
5.

Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study.

Manfredi A, Cassone G, Furini F, Gremese E, Venerito V, Atzeni F, Arrigoni E, Della Casa G, Cerri S, Govoni M, Petricca L, Iannone F, Salvarani C, Sebastiani M.

Intern Med J. 2019 Oct 29. doi: 10.1111/imj.14670. [Epub ahead of print]

PMID:
31661185
6.

Comorbid fibromyalgia impairs the effectiveness of biologic drugs in patients with psoriatic arthritis.

Iannone F, Nivuori M, Fornaro M, Venerito V, Cacciapaglia F, Lopalco G.

Rheumatology (Oxford). 2019 Oct 25. pii: kez505. doi: 10.1093/rheumatology/kez505. [Epub ahead of print]

PMID:
31652315
7.

Symmetrical Panniculitis in a Patient With Dermatomyositis: An Unusual Onset.

Fornaro M, Carlino G, Abbruzzese A, Piccinni AR, Iannone F.

J Clin Rheumatol. 2019 Oct 22. doi: 10.1097/RHU.0000000000001164. [Epub ahead of print] No abstract available.

PMID:
31651642
8.

Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study.

Imazio M, Andreis A, De Ferrari GM, Cremer PC, Mardigyan V, Maestroni S, Luis SA, Lopalco G, Emmi G, Lotan D, Marcolongo R, Lazaros G, De Biasio M, Cantarini L, Dagna L, Cercek AC, Pivetta E, Varma B, Berkson L, Tombetti E, Iannone F, Prisco D, Caforio ALP, Vassilopoulos D, Tousoulis D, De Luca G, Giustetto C, Rinaldi M, Oh JK, Klein AL, Brucato A, Adler Y.

Eur J Prev Cardiol. 2019 Oct 15:2047487319879534. doi: 10.1177/2047487319879534. [Epub ahead of print]

PMID:
31610707
9.

Response to: 'Response to: "Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients" by Fornaro et al' by Agca et al.

Fornaro M, Cacciapaglia F, Venerito V, Lopalco G, Iannone F.

Ann Rheum Dis. 2019 Oct 11. pii: annrheumdis-2019-216407. doi: 10.1136/annrheumdis-2019-216407. [Epub ahead of print] No abstract available.

PMID:
31604705
10.

Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus.

Fornaro M, Coladonato L, Venerito V, Cacciapalglia F, Lopalco G, Iannone F.

Rheumatology (Oxford). 2019 Oct 10. pii: kez442. doi: 10.1093/rheumatology/kez442. [Epub ahead of print] No abstract available.

PMID:
31600396
11.

LAV-BPIFB4 associates with reduced frailty in humans and its transfer prevents frailty progression in old mice.

Malavolta M, Dato S, Villa F, Rango F, Iannone F, Ferrario A, Maciag A, Ciaglia E, D'amato A, Carrizzo A, Basso A, Orlando F, Provinciali M, Madeddu P, Passarino G, Vecchione C, Rose G, Puca AA.

Aging (Albany NY). 2019 Aug 28;11(16):6555-6568. doi: 10.18632/aging.102209. Epub 2019 Aug 28.

12.

Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration.

Ørnbjerg LM, Brahe CH, Askling J, Ciurea A, Mann H, Onen F, Kristianslund EK, Nordström D, Santos MJ, Codreanu C, Gómez-Reino J, Rotar Z, Gudbjornsson B, Di Giuseppe D, Nissen MJ, Pavelka K, Birlik M, Kvien T, Eklund KK, Barcelos A, Ionescu R, Sanchez-Piedra C, Tomsic M, Geirsson ÁJ, Loft AG, van der Horst-Bruinsma I, Jones G, Iannone F, Hyldstrup L, Krogh NS, Hetland ML, Østergaard M.

Ann Rheum Dis. 2019 Nov;78(11):1536-1544. doi: 10.1136/annrheumdis-2019-215427. Epub 2019 Aug 20.

PMID:
31431486
13.

Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications.

Manetti M, Romano E, Rosa I, Fioretto BS, Praino E, Guiducci S, Iannone F, Ibba-Manneschi L, Matucci-Cerinic M.

J Clin Med. 2019 Aug 19;8(8). pii: E1256. doi: 10.3390/jcm8081256.

14.

Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual.

Fasano S, Riccardi A, Messiniti V, Caramaschi P, Rosato E, Maurer B, Smith V, Siegert E, De Langhe E, Riccieri V, Airó P, Mihai C, Avouac J, Zanatta E, Walker UA, Iannone F, García De la Peña Lefebvre P, Distler JHW, Vacca A, Distler O, Kowal-Bielecka O, Allanore Y, Valentini G.

Ann Rheum Dis. 2019 Dec;78(12):1681-1685. doi: 10.1136/annrheumdis-2019-215787. Epub 2019 Aug 17.

PMID:
31422354
15.

Real-world effectiveness of apremilast in multirefractory mucosal involvement of Behçet's disease.

Lopalco G, Venerito V, Leccese P, Emmi G, Cantarini L, Lascaro N, Di Scala G, Fabiani C, Rigante D, Iannone F.

Ann Rheum Dis. 2019 Dec;78(12):1736-1737. doi: 10.1136/annrheumdis-2019-215437. Epub 2019 Aug 10. No abstract available.

PMID:
31401548
16.

Transitional care of young people with juvenile idiopathic arthritis in Italy: results of a Delphi consensus survey.

Ravelli A, Sinigaglia L, Cimaz R, Alessio M, Breda L, Cattalini M, Consolaro A, Conti F, Cortis E, D'Angelo S, De Benedetti F, Doria A, Ferrari C, Gallizzi R, Govoni M, Gremese E, Iannone F, La Torre F, Maggio MC, Perricone R, Pontikaki I, Rossi F, Salaffi F, Simonini G, Caporali R; Italian Paediatric Rheumatology Study Group and the Italian Society of Rheumatology.

Clin Exp Rheumatol. 2019 Jul 25. [Epub ahead of print]

PMID:
31376254
17.

An observational prospective study on predictors of clinical response at six months in patients with active psoriatic arthritis treated with golimumab.

Scrivo R, Giardino AM, Salvarani C, Foti R, Afeltra A, Viapiana O, Giacomelli R, Salaffi F, Galeazzi M, Ramonda R, Ciccia F, Valesini G, Iannone F; Predicting MDA in PsA Study Group.

Clin Exp Rheumatol. 2019 Jul 8. [Epub ahead of print]

PMID:
31287400
18.

Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naïve patients with rheumatoid arthritis.

Lauper K, Mongin D, Iannone F, Kristianslund EK, Kvien TK, Nordström DC, Pavelka K, Pombo-Suarez M, Rotar Z, Santos MJ, Codreanu C, Lukina G, Gale SL, John M, Luder Y, Courvoisier DS, Gabay C.

Semin Arthritis Rheum. 2019 Jun 28. pii: S0049-0172(19)30203-3. doi: 10.1016/j.semarthrit.2019.06.020. [Epub ahead of print]

19.

Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: the InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device).

Manfredi A, Cassone G, Cerri S, Venerito V, Fedele AL, Trevisani M, Furini F, Addimanda O, Pancaldi F, Della Casa G, D'Amico R, Vicini R, Sandri G, Torricelli P, Celentano I, Bortoluzzi A, Malavolta N, Meliconi R, Iannone F, Gremese E, Luppi F, Salvarani C, Sebastiani M; GISEA (Gruppo Italiano Studio Early Arthritis).

BMC Pulm Med. 2019 Jun 20;19(1):111. doi: 10.1186/s12890-019-0875-x.

20.

Drug retention of biological DMARD in rheumatoid arthritis patients: the role of baseline characteristics and disease evolution.

Lauper K, Mongin D, Alpizar-Rodriguez D, Codreanu C, Iannone F, Kristianslund EK, Kvien TK, Pavelka K, Pombo-Suarez M, Santos MJ, Gabay C, Finckh A, Courvoisier DS.

Rheumatology (Oxford). 2019 Jun 17. pii: kez221. doi: 10.1093/rheumatology/kez221. [Epub ahead of print]

PMID:
31209481
21.

Paradoxical Pustular Psoriasis in a Patient With Psoriatic Arthritis on Secukinumab Treatment.

Abbruzzese A, Venerito V, Lopalco G, Fornaro M, Giannotta M, Iannone F.

J Clin Rheumatol. 2019 Jun 11. doi: 10.1097/RHU.0000000000001076. [Epub ahead of print] No abstract available.

PMID:
31192857
22.

Autophagy markers LC3 and p62 accumulate in immune-mediated necrotizing myopathy.

Girolamo F, Lia A, Annese T, Giannini M, Amati A, D'Abbicco D, Tampoia M, Virgintino D, Ribatti D, Serlenga L, Iannone F, Trojano M.

Muscle Nerve. 2019 Sep;60(3):315-327. doi: 10.1002/mus.26608. Epub 2019 Jun 21.

PMID:
31172530
23.

Influence of changes in cholesterol levels and disease activity on the 10 years cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients.

Fornaro M, Cacciapaglia F, Venerito V, Lopalco G, Iannone F.

Ann Rheum Dis. 2019 May 29. pii: annrheumdis-2019-215715. doi: 10.1136/annrheumdis-2019-215715. [Epub ahead of print] No abstract available.

PMID:
31142479
24.

Inter-Individual Variability in Xenobiotic-Metabolizing Enzymes: Implications for Human Aging and Longevity.

Crocco P, Montesanto A, Dato S, Geracitano S, Iannone F, Passarino G, Rose G.

Genes (Basel). 2019 May 27;10(5). pii: E403. doi: 10.3390/genes10050403.

25.

Body mass index as a driver of selection of biologic therapy in rheumatoid arthritis. Results from the US-CLARA study.

Di Carlo M, Salaffi F, Gremese E, Iannone F, Lapadula G, Ferraccioli G; GISEA Study Group.

Eur J Intern Med. 2019 Aug;66:57-61. doi: 10.1016/j.ejim.2019.05.017. Epub 2019 May 18.

PMID:
31113709
26.

Retrospective evaluation of patient profiling and effectiveness of apremilast in an Italian multicentric cohort of psoriatic arthritis patients.

Favalli EG, Conti F, Selmi C, Iannone F, Bucci R, D'Onofrio F, Carlino G, Santo L, Semeraro A, Zuccaro C, D'Angelo S, Atzeni F, Marino F, Monti S, Guidelli GM, Spinelli FR, Biggioggero M, Caporali R.

Clin Exp Rheumatol. 2019 May 10. [Epub ahead of print]

PMID:
31074721
27.

How Important Are the Standard Measures in Assessing the Clinical Outcomes in Psoriatic Arthritis in Real-world Settings?

Iannone F.

J Rheumatol. 2019 May;46(5):450-452. doi: 10.3899/jrheum.180906. No abstract available.

PMID:
31043497
28.

Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.

Lopalco G, Venerito V, Cantarini L, Emmi G, Salaffi F, Di Carlo M, Tafuri S, Gentileschi S, Di Scala G, Nivuori M, Cacciapaglia F, Galeazzi M, Lapadula G, Iannone F.

Clin Exp Rheumatol. 2019 Sep-Oct;37(5):762-767. Epub 2019 Apr 16.

PMID:
31025925
29.

Long-Term Retention Rate of Anakinra in Adult Onset Still's Disease and Predictive Factors for Treatment Response.

Vitale A, Cavalli G, Colafrancesco S, Priori R, Valesini G, Argolini LM, Baldissera E, Bartoloni E, Cammelli D, Canestrari G, Sota J, Cavallaro E, Massaro MG, Ruscitti P, Cipriani P, De Marchi G, De Vita S, Emmi G, Ferraccioli G, Frassi M, Gerli R, Gremese E, Iannone F, Lapadula G, Lopalco G, Manna R, Mathieu A, Montecucco C, Mosca M, Piazza I, Piga M, Pontikaki I, Romano M, Rossi S, Rossini M, Silvestri E, Stagnaro C, Talarico R, Tincani A, Viapiana O, Vitiello G, Galozzi P, Sfriso P, Gaggiano C, Rigante D, Dagna L, Giacomelli R, Cantarini L.

Front Pharmacol. 2019 Apr 2;10:296. doi: 10.3389/fphar.2019.00296. eCollection 2019.

30.

Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases.

Bettiol A, Lopalco G, Emmi G, Cantarini L, Urban ML, Vitale A, Denora N, Lopalco A, Cutrignelli A, Lopedota A, Venerito V, Fornaro M, Vannacci A, Rigante D, Cimaz R, Iannone F.

Int J Mol Sci. 2019 Apr 17;20(8). pii: E1898. doi: 10.3390/ijms20081898. Review.

31.

Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study.

Elhai M, Boubaya M, Distler O, Smith V, Matucci-Cerinic M, Alegre Sancho JJ, Truchetet ME, Braun-Moscovici Y, Iannone F, Novikov PI, Lescoat A, Siegert E, Castellví I, Airó P, Vettori S, De Langhe E, Hachulla E, Erler A, Ananieva L, Krusche M, López-Longo FJ, Distler JHW, Hunzelmann N, Hoffmann-Vold AM, Riccieri V, Hsu VM, Pozzi MR, Ancuta C, Rosato E, Mihai C, Kuwana M, Saketkoo LA, Chizzolini C, Hesselstrand R, Ullman S, Yavuz S, Rednic S, Caimmi C, Bloch-Queyrat C, Allanore Y; for EUSTAR network.

Ann Rheum Dis. 2019 Jul;78(7):979-987. doi: 10.1136/annrheumdis-2018-214816. Epub 2019 Apr 9.

PMID:
30967395
32.

Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis.

Tosi GM, Sota J, Vitale A, Rigante D, Emmi G, Lopalco G, Guerriero S, Orlando I, Iannone F, Frediani B, Angotti R, Messina M, Galeazzi M, Vannozzi L, Cantarini L, Fabiani C.

Clin Exp Rheumatol. 2019 Jul-Aug;37(4):680-683. Epub 2019 Apr 3.

33.

Effectiveness of Certolizumab-Pegol in Rheumatoid Arthritis, Spondyloarthritis, and Psoriatic Arthritis Based on the BIOPURE Registry: Can Early Response Predict Late Outcomes?

Iannone F, Semeraro A, Carlino G, Santo L, Bucci R, Quarta L, Maruotti N, Zuccaro C, Marsico A, Falappone PCF, Mazzotta D, Cantatore FP, Muratore M, Lapadula G.

Clin Drug Investig. 2019 Jun;39(6):565-575. doi: 10.1007/s40261-019-00782-9.

PMID:
30941736
34.

Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE).

Carlino G, Fornaro M, Santo L, Bucci R, Semeraro A, Quarta L, D'Onofrio F, Marsico A, Zuccaro C, Falappone PC, Mazzotta D, Cantatore FP, Muratore M, Iannone F.

Reumatismo. 2019 Apr 1;71(1):24-30. doi: 10.4081/reumatismo.2019.1154.

35.

Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study.

Bitossi A, Bettiol A, Silvestri E, Di Scala G, Bacherini D, Lopalco G, Venerito V, Iannone F, Vitale A, Tosi GM, Prisco D, Rizzo S, Fabiani C, Cantarini L, Virgili G, Vannozzi L, Emmi G.

Mediators Inflamm. 2019 Feb 10;2019:1623847. doi: 10.1155/2019/1623847. eCollection 2019.

36.

Rate of serious infections in spondyloarthropathy patients treated with anti-tumour necrosis factor drugs: a survey from the Italian registry GISEA.

Atzeni F, Sarzi-Puttini P, Sebastiani M, Panetta V, Salaffi F, Iannone F, Carletto A, Foti R, Gremese E, Govoni M, Marchesoni A, Favalli E, Gorla R, Ramonda R, Ferraccioli G, Lapadula G; GISEA group.

Clin Exp Rheumatol. 2019 Jul-Aug;37(4):649-655. Epub 2019 Feb 11.

PMID:
30767865
37.

Inositol Polyphosphate Multikinase (IPMK), a Gene Coding for a Potential Moonlighting Protein, Contributes to Human Female Longevity.

De Rango F, Crocco P, Iannone F, Saiardi A, Passarino G, Dato S, Rose G.

Genes (Basel). 2019 Feb 8;10(2). pii: E125. doi: 10.3390/genes10020125.

38.

Is retinal microvascular damage an early manifestation of systemic sclerosis?

Iannone F, Rotondo C.

Ann Rheum Dis. 2019 Feb 9. pii: annrheumdis-2019-215127. doi: 10.1136/annrheumdis-2019-215127. [Epub ahead of print] No abstract available.

PMID:
30739084
39.

Efficacy of anti-tumour necrosis factor-α monoclonal antibodies in patients with non-infectious anterior uveitis.

Fabiani C, Vitale A, Rigante D, Emmi G, Lopalco G, Sota J, Vannozzi L, Guerriero S, Bitossi A, Orlando I, Franceschini R, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.

Clin Exp Rheumatol. 2019 Mar-Apr;37(2):301-305. Epub 2019 Jan 18.

40.

A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis.

Venerito V, Lopalco G, Cacciapaglia F, Fornaro M, Iannone F.

Clin Rheumatol. 2019 May;38(5):1309-1317. doi: 10.1007/s10067-018-04406-z. Epub 2019 Jan 10. Review.

PMID:
30628014
41.

Splenic Infarction as Only Manifestation of Antiphospholipid Syndrome in a Patient With Rheumatoid Arthritis.

Venerito V, Lopalco G, Cacciapaglia F, Coladonato L, Iannone F.

J Clin Rheumatol. 2018 Dec 28. doi: 10.1097/RHU.0000000000000964. [Epub ahead of print] No abstract available.

PMID:
30601167
42.

Epidemiological profile of non-infectious uveitis from the rheumatologist's perspective: a survey from two tertiary referral centres in Italy.

Lopalco G, Venerito V, Sota J, Rigante D, Guerriero S, Orlando I, Franceschini R, Favale R, Lapadula G, Castelli B, Frediani B, Galeazzi M, La Torre F, Iannone F, Tosi GM, Fabiani C, Cantarini L.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6 Suppl 115):68-73. Epub 2018 Dec 12.

PMID:
30582503
43.

Radiologist-rheumatologist multidisciplinary approach in the management of axial spondyloarthritis: a Delphi consensus statement.

Marchesoni A, D'Angelo S, Anzidei M, Bortolotti R, Cantini F, Caramella D, Carotti M, Chimenti MS, Delle Sedie A, Egan CG, Fabbroni M, Frediani B, Fusaro E, Galeazzi M, Gallazzi MB, Gentileschi S, Gentili F, Gerli R, Gilio M, Iannone F, La Paglia E, Lubrano E, Macarini L, Olivieri I, Pellerito R, Ramonda R, Salvarani C, Scarano E, Scarpa R, Spaggiari L, Spanò A, Zawaideh JP, Mazzei MA; SHARE Study Group.

Clin Exp Rheumatol. 2019 Jul-Aug;37(4):575-584. Epub 2018 Nov 16.

PMID:
30557127
44.

Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors.

Barone M, Viggiani MT, Anelli MG, Fanizzi R, Lorusso O, Lopalco G, Cantarini L, Di Leo A, Lapadula G, Iannone F.

J Clin Med. 2018 Dec 1;7(12). pii: E504. doi: 10.3390/jcm7120504.

45.

Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries.

Lauper K, Mongin D, Iannone F, Klami Kristianslund E, Kvien TK, Nordström D, Pavelka K, Pombo-Suarez M, Rotar Z, Santos MJ, Codreanu C, Lukina G, Courvoisier DS, Gabay C.

RMD Open. 2018 Nov 5;4(2):e000809. doi: 10.1136/rmdopen-2018-000809. eCollection 2018.

46.

Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study.

Sebastiani M, Triantafyllias K, Manfredi A, González-Gay MA, Palmou-Fontana N, Cassone G, Drott U, Delbrück C, Rojas-Serrano J, Bertolazzi C, Nuño L, Giannini M, Iannone F, Vicente EF, Castañeda S, Selva-O'Callaghan A, Trallero Araguas E, Emmi G, Iuliano A, Bauhammer J, Miehle N, Parisi S, Cavagna L, Codullo V, Montecucco C, Lopez-Longo FJ, Martínez-Barrio J, Nieto-González JC, Vichi S, Confalonieri M, Tomietto P, Bergner R, Sulli A, Bonella F, Furini F, Scirè CA, Bortoluzzi A, Specker C, Barsotti S, Neri R, Mosca M, Caproni M, Weinmann-Menke J, Schwarting A, Smith V, Cutolo M; American and European Network of Antisynthetase Syndrome Collaborative Group.

J Rheumatol. 2019 Mar;46(3):279-284. doi: 10.3899/jrheum.180355. Epub 2018 Nov 15.

PMID:
30442823
47.

Lipids and Atherogenic Indices Fluctuation in Rheumatoid Arthritis Patients on Long-Term Tocilizumab Treatment.

Cacciapaglia F, Anelli MG, Rinaldi A, Fornaro M, Lopalco G, Scioscia C, Lapadula G, Iannone F.

Mediators Inflamm. 2018 Oct 14;2018:2453265. doi: 10.1155/2018/2453265. eCollection 2018.

48.

Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease.

Lucherini OM, Lopalco G, Cantarini L, Emmi G, Lopalco A, Venerito V, Vitale A, Iannone F.

Immunol Lett. 2018 Sep;201:38-44. doi: 10.1016/j.imlet.2018.10.013. Epub 2018 Oct 29.

PMID:
30385329
49.

Long-term effectiveness and safety of switching from originator to biosimilar infliximab in patients with Behçet's disease.

Lopalco G, Venerito V, Cantarini L, Emmi G, Prisco D, Iannone F.

Intern Emerg Med. 2019 Aug;14(5):719-722. doi: 10.1007/s11739-018-1970-3. Epub 2018 Oct 25. No abstract available.

PMID:
30361849
50.

The profiling of axial spondyloarthritis patient candidate to a biologic therapy: Consensus from a Delphi-panel of Italian experts.

Favalli EG, Becciolini A, Caporali R, Todoerti M, Iannone F, Dinoia L, Sebastiani M, Spinella A, Gremese E, Cianci F, Atzeni F, Bandinelli F, Ferraccioli G, Lapadula G; GISEA Study Group.

Autoimmun Rev. 2018 Dec;17(12):1251-1258. doi: 10.1016/j.autrev.2018.07.002. Epub 2018 Oct 16. Review.

PMID:
30339886

Supplemental Content

Loading ...
Support Center